Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Optimizing Patient-Specific Medication Regimen Policies Using Wearable Sensors in Parkinson’s Disease

Journal Article · · Management Science
 [1];  [2];  [3];  [4]
  1. Florida State Univ., Tallahassee, FL (United States)
  2. Univ. of Tennessee, Knoxville, TN (United States)
  3. Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
  4. Zucker School of Medicine, Great Neck, NY (United States)

Effective treatment of Parkinson’s disease (PD) is a continual challenge for healthcare providers, and providers can benefit from leveraging emerging technologies to supplement traditional clinic care. We develop a data-driven reinforcement learning (RL) framework to optimize PD medication regimens through wearable sensors. We leverage a data set of n = 26 PD patients who wore wrist-mounted movement trackers for two separate six-day periods. Using these data, we first build and validate a simulation model of how individual patients’ movement symptoms respond to medication administration. We then pair this simulation model with an on-policy RL algorithm that recommends optimal medication types, timing, and dosages during the day while incorporating human-in-the-loop considerations on medication administration. The results show that the RL-prescribed medication regimens outperform physicians’ medication regimens, despite physicians having access to the same data as the RL agent. To validate our results, we assess our wearable-based RL medication regimens using n = 399 PD patients from the Parkinson’s Progression Markers Initiative data set. We show that the wearable-based RL medication regimens would lead to significant symptom improvement for these patients, even more so than training RL policies directly from this data set. In doing so, we show that RL models from even small data sets of wearable data can offer novel, generalizable clinical insights and medication strategies, which may outperform those derived from larger data sets without wearable data.

Research Organization:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE Office of Science (SC)
Grant/Contract Number:
AC05-00OR22725
OSTI ID:
2000318
Journal Information:
Management Science, Vol. 69, Issue 10; ISSN 0025-1909
Publisher:
Institute for Operations Research and the Management Sciences (INFORMS)Copyright Statement
Country of Publication:
United States
Language:
English

References (40)

Artificial intelligence for assisting diagnostics and assessment of Parkinson’s disease—A review journal September 2019
Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily journal February 2009
Systematic review of levodopa dose equivalency reporting in Parkinson's disease journal November 2010
Neurologist care in Parkinson disease: A utilization, outcomes, and survival study journal August 2011
Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective journal March 2008
The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort journal October 2018
Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa–Levodopa journal February 2017
Monitoring behavioral symptoms of dementia using activity trackers journal September 2020
Model-based and Model-free Machine Learning Techniques for Diagnostic Prediction and Classification of Clinical Outcomes in Parkinson’s Disease journal May 2018
Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease journal February 2014
Treating Epilepsy via Adaptive Neurostimulation: a Reinforcement Learning Approach journal August 2009
A review on microelectrode recording selection of features for machine learning in deep brain stimulation surgery for Parkinson’s disease journal January 2019
Features and performance of some outlier detection methods journal October 2011
Stratifying Parkinson’s Patients With STN-DBS Into High-Frequency or 60 Hz-Frequency Modulation Using a Computational Model journal July 2017
Improving Deep Reinforcement Learning With Transitional Variational Autoencoders: A Healthcare Application journal June 2021
Guidelines for reinforcement learning in healthcare journal January 2019
Remote health monitoring of elderly through wearable sensors journal January 2019
Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia? journal March 2013
Automated Assessment of Bradykinesia and Dyskinesia in Parkinson's Disease journal January 2012
Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet®), sustained-release carbidopa-levodopa (Sinemet® CR), and carbidopa-levodopa-entacapone (: The Journal of Clinical Pharmacology journal May 2015
A Supervised Machine Learning Approach to Detect the On/Off State in Parkinson’s Disease Using Wearable Based Gait Signals journal June 2020
Dosing Frequency and Medication Adherence in Chronic Disease journal September 2012
Role of the Personal KinetiGraph in the routine clinical assessment of Parkinson’s disease: recommendations from an expert panel journal July 2018
Just-in-Time Adaptive Interventions (JITAIs) in Mobile Health: Key Components and Design Principles for Ongoing Health Behavior Support journal December 2017
Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide journal March 2020
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire journal December 2007
Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial journal April 2013
Comparison Between a Fast and a Slow Release Preparation of Levodopa and a Combination of the Two journal February 1994
Validity of a commercial wearable sleep tracker in adult insomnia disorder patients and good sleepers journal June 2017
Optimizing Clinical Assessments in Parkinson's Disease Through the Use of Wearable Sensors and Data Driven Modeling journal September 2018
On-line policy learning and adaptation for real-time personalization of an artificial pancreas journal March 2015
Reinforcement learning application in diabetes blood glucose control: A systematic review journal April 2020
The promise of telemedicine for chronic neurological disorders: the example of Parkinson's disease journal July 2017
Machine Learning’s Application in Deep Brain Stimulation for Parkinson’s Disease: A Review journal November 2020
Pros and cons of apomorphine and l-dopa continuous infusion in advanced Parkinson's disease journal December 2009
Evaluation of Clinical Utility of the Personal KinetiGraph® in the Management of Parkinson Disease journal January 2019
Computational medication regimen for Parkinson’s disease using reinforcement learning journal April 2021
Motor response to apomorphine and levodopa in asymmetric Parkinson's disease. journal May 1994
Minimal clinically important change on the unified Parkinson's disease rating scale journal January 2006
Machine Learning Application to Quantify the Tremor Level for Parkinson’s Disease Patients journal January 2018